secwatch.observer — SEC 8-K summary
======================================

Issuer:     DarioHealth Corp. (DRIO)
CIK:        0001533998
Form:       8-K
Filed at:   2026-07-22T21:19:14+00:00
Accession:  0001104659-26-085900
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DarioHealth prices $23.5M registered direct offering of common stock and pre-funded warrants
--------------------------------------------------------------------------------

- Gross proceeds ~$23.5M from sale of 3.45M shares (or equivalents) at $6.80/share.
- Offering includes 2.44M shares and pre-funded warrants for 1.02M shares; board member purchased 14,430 shares at $6.93.
- Net proceeds for working capital, investments, acquisitions, and general corporate purposes.
- Closing expected July 23, 2026; A.G.P./Alliance Global Partners as sole placement agent with 6% fee.
- 30-day restricted period on further equity issuance (except existing ATM facility).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533998/000110465926085900/0001104659-26-085900-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533998/000110465926085900/tm2621105d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-085900

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer